NRAS and differentiated thyroid carcinoma: Some authors have also suggested the role of NRAS exon 61 mutation in the progression of PDTC from well-differentiated thyroid carcinoma [32,34] and TERT-p mutations as the most common alterations in PDTC [23,35].